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About this briefing 
This briefing aims to provide an update of the best available evidence from 
systematic reviews* or reviews of effective interventions to reduce drug 
misuse among pregnant women. It is based on a review of the evidence 
undertaken in 2015 and early 2016. 
 
 
Key points 
There is little robust evidence about the effectiveness of interventions to 
reduce illicit drug misuse among pregnant women or mothers in the early 
postpartum period. Most of the evidence comes from studies that have been 
carried out in the USA. Key findings indicate that: 
 
• Pharmacological interventions: there is no significant difference 
between the effectiveness of methadone, buprenorphine or slow-
release morphine in the treatment of pregnant women who are 
addicted to opiates. 
• Psychosocial interventions: there is no significant difference in the 
treatment outcomes between psychosocial interventions compared to 
usual care. 
• Brief intervention: there is limited but promising evidence about the 
effectiveness of brief interventions to reduce illicit drug use among 
postpartum women. 
• Home visits: there is insufficient evidence to recommend the routine 
use of home visits in response to pregnant or postpartum women with 
an illicit drug problem. 
                                                 
* A systematic review is a complex and time-consuming approach for summarising the results of 
several carefully designed studies (i.e., controlled trials). As the authors pool together numerical data 
about the effects of interventions through a process called meta-analyses these reviews are 
extremely valuable. They also consider the evidence about the benefits and/or harm arising from 
specific interventions. In this way, systematic reviews summarise the existing research on a topic and 
the findings are often used to inform recommendations for healthcare policy and practice. 
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• Any intervention to address drug misuse during pregnancy needs to 
take into account other complex lifestyle factors and circumstances. 
These impact on pregnant and postpartum women and may therefore 
require multiple interventions. 
 
Background 
Illicit drug use (including cocaine, amphetamines, opioids and marijuana) 
during pregnancy has been associated with a wide range of adverse neonatal 
outcomes, including intrauterine growth restriction; preterm birth; lower birth 
weight; neonatal abstinence syndrome; fetal distress; neurocognitive delays 
and impairment, and drug misuse later in adolescence.1, 2, 3   
 
During the postpartum period, illicit drug use is also associated with an 
increased risk of child neglect, violence exposure, physical abuse, and 
maternal mental health issues.1 
 
All of the commonly used opiates, including heroin and methadone, can 
produce neonatal abstinence syndrome in infants born to opiate dependent 
mothers. Neonatal abstinence syndrome includes all of the symptoms of adult 
withdrawal syndrome in addition to irritability, poorly coordinated sucking and, 
in the most severe cases, seizures and death.4 Furthermore, women who are 
injecting drugs are also at risk of infection including hepatitis C and HIV, with 
the potential for vertical transmission* to the infant.3 
 
Mother–infant attachment and responsiveness is also compromised through 
drug misuse, with postnatal depression and domestic abuse further 
complicating the mother–infant relationship. Mothers subsequently tend to be 
reluctant to attend health facilities for education, medical treatment or social 
support.3 
                                                 
* Vertical transmission is defined as the passage of a disease-causing agent (pathogen) from mother 
to baby during the period immediately before and after birth. Transmission might occur across the 
placenta, in the breast milk, or through direct contact during or after birth. 
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Drug u  in the Scottish general population  
Similar to the rest of the UK and Europe, the illicit use of drugs – particularly 
opiates, benzodiazepines and psycho-stimulants – causes significant 
problems in Scotland. During 2014/15, drug use in Scotland was reported in 
6% of all adults; however this increased to 18.8% among those aged 16 to 24 
years of age. 
 
The key issues with drug use are primarily social, such as increased criminal 
behaviour, prostitution, unemployment, family breakdown and homelessness. 
Other problems are more clearly associated with health issues, including the 
transmission of communicable diseases (such as HIV and hepatitis) and 
injecting-related injuries. Because the drug using population is hidden, 
prevalence figures can only ever be estimates. (See the Scottish Public 
Health Observatory (ScotPHO) drugs pages for more detail.) 
 
Drug use among children has continuously declined since 1998. In 2013 
approximately 9% of 15 year olds and 2% of 13 year olds reported having 
taken drugs in the last month, compared to 24% and 8% in 1998. The most 
commonly reported illicit drug use was cannabis, followed by stimulants, 
psychedelics, gas, glue or other solvents and opiates (See the Scottish 
Schools Adolescent Lifestyle and Substance Use Survey (SALSUS) report 
2013 for more detail.) 
 
 
Drug use during pregnancy 
Illicit drug use among pregnant mothers in Scotland is very low and is 
declining. Only 1% of pregnancies recorded drug misuse in 2014/15, of which 
around 50% was opiate misuse. However, the rate of maternity bookings at 
which drug misuse was recorded varies considerably across Scotland, with 
almost a five-fold difference between some health board areas (See the 
ScotPHO drugs pages for more detail.) 
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In relation to deprivation, the rate of maternity bookings in 2014/15 during 
which drug misuse was recorded was six times higher in the most deprived 
category of social deprivation (22 per 1000 births) compared to the least 
deprived (3.5 per 1000 births). 
 
With regard to birth outcomes, 80% of mothers for whom drug misuse during 
pregnancy was recorded had a full-term normal birth. This compared with 
90% of all births. Thirteen per cent of births in which maternal drug misuse 
was recorded were pre-term births – almost double the percentage recorded 
among all births (7%). 
 
The proportion of babies affected by maternal drug use (where the baby was 
affected by, or had withdrawal symptoms from, maternal use of drugs) was 6 
per 1000 live births for the period 2012/13 and 2014/15. When compared to a 
similar aggregated rate of live births to mothers for whom drug misuse was 
recorded (13 per 1000 live births for the period 2012/13 and 2014/15), it can 
be seen that just under half of the babies for whom maternal drug misuse was 
recorded were affected by or had withdrawal symptoms as a result of 
maternal drug use. 
 
Although the numbers of infants affected by maternal drug use seem relatively 
small, if we take account of the impact that drug misuse can have on the 
mother, her family and neonatal/child outcomes, the overall impact for the 
child and family could be considerable. 
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Effective evidence summary 
 
Pharmacological interventions 
Maintenance treatment for opiate dependent women with methadone and 
buprenorphine during pregnancy and in the postpartum period can provide a 
steady concentration of opiate in the pregnant woman’s blood and can 
therefore help to prevent the adverse impact on the fetus of repeated 
substance withdrawal. These treatments also help to reduce illicit drug use, 
improve compliance with obstetric care and improve neonatal birth weight. 
Nonetheless, despite such treatments neonatal abstinence syndrome 
remains.4 
 
Currently the evidence is still too limited to draw firm conclusions about 
whether methadone or buprenorphine treatment during pregnancy is the most 
effective. This highlights the need for more randomised controlled trials with 
adequate sample size to enable the comparison of different maintenance 
treatments. 
 
Findings from one systematic review4 found evidence of insufficient 
differences between methadone and buprenorphine or slow-release morphine 
to conclude that one treatment was superior over another in response to all 
relevant birth and neonatal outcomes. While methadone seems superior in 
relation to retaining patients in treatment programmes, buprenorphine seems 
to result in less severe neonatal abstinence syndrome. 
 
 
Psychosocial interventions 
Despite some evidence of effective psychosocial interventions in response to 
drug use among the general population, it is unclear whether psychosocial 
interventions are effective in response to drug use among pregnant women 
due to a lack of specific studies. Even where trials were conducted with 
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pregnant women, maternal and neonatal outcomes were rarely captured in 
the reporting of findings. 
 
Evidence from one systematic review2 compared contingency management 
(such as incentives and vouchers) and motivational interviewing-based 
interventions with a control group. The control group comprised usual care 
consisting of pharmacological treatment, such as methadone maintenance, 
counselling, prenatal care, sexually transmitted infection (STI) counselling and 
testing, the provision of transport to care provider, and/or childcare. Although 
few included studies reported on maternal and neonatal outcomes, no 
differences were observed in relation to pre-term birth, maternal toxicity at 
delivery, or low birth weight. However, the results showed that neonates 
remained in hospital for fewer days after delivery in the contingency 
management intervention groups. 
 
 
Brief interventions 
Among pregnant women, brief motivational interventions* have been shown to 
modestly improve smoking cessation rates5 and alcohol abstinence6. 
However, few studies have examined the effect of brief interventions in 
response to illicit drug use during pregnancy or in the postpartum period. 
 
Evidence from one review1 found limited yet promising evidence of the benefit 
of brief interventions to reduce illicit drug use among postpartum women. Two 
of the four included randomised controlled trials tested similar computer-
delivered single-session interventions but only one showed positive benefits in 
the intervention group in relation to their self-reported abstinence and 
toxicology screening at three and six months. Neither of the remaining 
randomised controlled trials that assessed specialised treatment use found 
differences between the intervention and control groups. 
 
                                                 
* Motivational interviewing is a directive, client-centred counselling style for eliciting behaviour 
change by helping clients to explore and resolve ambivalence. 
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Home visits 
Home visits are one way of facilitating links between pregnant or new mothers 
and a particular service. Home visits can include pregnancy care, health 
surveillance and promotion, counselling, social support, education, facilitation 
of mother–infant interaction and the promotion of parenting as well as drug or 
alcohol services. 
 
Evidence from one systematic review3 found insufficient evidence to 
recommend the routine use of home visits for pregnant or postpartum women 
with a drug or alcohol problem. 
 
 
Inequality and equality 
There is clear evidence that illicit drug misuse during pregnancy is more 
prevalent among women living in deprived areas (six times higher) compared 
to women living in affluent areas. (See the ScotPHO drugs pages for more 
detail.) In view of other adverse lifestyle factors, such as alcohol or tobacco 
use, as well as economic instability and family relations, any drug misuse 
intervention needs to address a wide range of complex factors rather than 
taking a single approach to reduce or prevent drug misuse. 
 
Based on Macintyre’s framework of guiding principles for effective policies 
and interventions to address health inequalities for the 2008 Ministerial Task 
Force, interventions for problem drug users are assessed as most likely to 
have some impact on health inequalities, as they target a disadvantaged 
group and provide intensive support.7 
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Conclusion 
Most of the evidence included in this briefing is relatively old and focused on 
populations in the USA, thereby limiting their relevance to a Scottish context. 
Few of the reviews highlight effective interventions. This may be partly due to 
the limited number of studies, the low quality and potential bias of included 
studies, as well as a lack of RCTs conducted with pregnant and postpartum 
women who have an illicit drug problem. 
 
Given the complex and often chaotic lives illicit drug users experience, 
combined with pregnancy, it is unlikely that a single intervention will be 
effective in reducing their drug misuse. An integrated, person-centred 
approach is likely to be required to enable pregnant mothers to be drug-free. 
 
 
Scottish policy links 
The Road to Recovery: A New Approach to Tackling Scotland’s drug problem 
(2008). The Scottish Government's 2008 national drugs strategy mainly 
focuses on recovery for drug users, but takes a wider, more holistic approach 
by looking at prevention, treatment and rehabilitation, education, enforcement 
and protection of children.  
www.gov.scot/Resource/Doc/224480/0060586.pdf 
 
Getting our priorities right (2013). This Scottish Government’s guidance is to 
provide an updated good practice framework for all child and adult service 
practitioners working with vulnerable children and families affected by 
problematic parental alcohol and/or drug use. It has been updated in the 
particular context of the national GIRFEC approach and the Recovery 
Agendas, both of which have a focus on ‘whole family’ recovery. 
www.gov.scot/Resource/0042/00420685.pdf 
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